Focus: Gossamer Bio is a small-molecule focused biotech company headquartered in San Diego with a pipeline spanning respiratory, cardiovascular, gastrointestinal, and oncology indications. The company operates as a clinical-stage biotech with multiple programs in Phase 1-3 development.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Gossamer Bio is a science-focused pre-revenue biotech best suited for early-career researchers seeking deep pipeline exposure and clinical trial leadership, but current hiring freeze signals limited near-term opportunity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Gossamer Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Gossamer Bio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles